Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Entera Bio

Entera Bio
2009 FOUNDED
PUBLIC STATUS
11-20 EMPLOYEES
ENTX STOCK SYMBOL
$2.04 SHARE PRICE (As of Monday Closing)
Description

Entera Bio Ltd is a clinical-stage biopharmaceutical company which focuses on the development and commercialization of orally delivered large molecule therapeutics for use in orphan indications and other areas with significant unmet medical need. The lead oral parathyroid hormone (PTH) product candidate, EB612 for the treatment of hypoparathyroidism. The company also develops a varied oral PTH product candidate, EB613 for the treatment of osteoporosis.

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
NAS
Primary Office
  • Kiryat Hadassah, Minrav Building
  • 5th Floor, PO Box 12117
  • Jerusalem 91220
  • Israel
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Entera Bio’s full profile, request a free trial.

Entera Bio Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$1.35 - $6.29 $24.8M $2.25 -$0.80 5.93K 12.2M

Entera Bio Financials Summary

In Thousands,
USD
TTM
30-Sep-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 22,788 63,215
Revenue 634 500 0 0
EBITDA (9,798) (10,250) (11,154) (1,164)
Net Income (10,000) (10,304) (11,197) (1,199)
Total Assets 7,323 13,341 13,278 6,286
Total Debt 329 0 3,893 14,720
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Entera Bio Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Entera Bio‘s full profile, request access.

Request full access to PitchBook

Entera Bio Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Entera Bio‘s full profile, request access.

Request full access to PitchBook

Entera Bio Executive Team (8)

Name Title Board
Seat
Contact
Info
Roger Garceau MD Board Member & Executive
Phillip Schwartz Ph.D Chief Executive Officer & Board Member
Mira Rosenzweig Chief Financial Officer & Chief Accounting Officer
Hillel Galitzer Ph.D Chief Operating Officer
Gregory Burshtein Ph.D Director, Pharmaceutical Research & Development

2 Former Executives

You’re viewing 5 of 8 executives. Get the full list »

Entera Bio Board Members (14)

Name Representing Role Since Contact
Info
Faith Charles JD Self Board Member 000 0000
Gerald Lieberman Self Board Member 000 0000
Gerald Ostrov Self Board Member 000 0000
Kenneth Abramowitz Self Board Member 000 0000
Miranda Toledano Self Board Member 000 0000

5 Former Board Members

You’re viewing 5 of 14 board members. Get the full list »